Top Markets
#1 Black Phoenix Black Phoenix +21,376.82%
#2 Nesa Nesa +750.60%
#3 ADO Protocol ADO Protocol +101.91%
#4 Cortex Cortex +93.72%
#5 Ontology Gas Ontology Gas +65.41%
#6 Kinesis Silver Kinesis Silver +54.02%
#7 OpenEden OpenEden +36.96%
#8 Magma Finance Magma Finance +24.21%
#9 QuantixAI QuantixAI +23.16%
#10 EXOD EXOD +22.78%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.

Steminent Biotherapeutics Inc.

7729
Clasificación en acciones #18872
Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to... Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to pioneering novel cellular therapeutics, with a primary focus on the research and development of innovative stem cell drugs. Their flagship product is Stemchymal, which is recognized for its significant therapeutic benefits and broad range of potential applications. The firm was established on December 18, 2007, and operates from its headquarters in Taipei, Taiwan.
Precio por acción
$2.51
Capitalización bursátil
$183.34M
Cambio (1 día)
0.90%
Cambio (1 año)
91.17%
País
TW
Comercio Steminent Biotherapeutics Inc. (7729)

Categoría

Healthcare
Ganancias de Steminent Biotherapeutics Inc. (7729)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Steminent Biotherapeutics Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Steminent Biotherapeutics Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH